The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. (2015)
Attributed to:
MICA: MRC Centre for Neuromuscular Diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13023-015-0258-1
PubMed Identifier: 25902795
Publication URI: http://europepmc.org/abstract/MED/25902795
Type: Journal Article/Review
Volume: 10
Parent Publication: Orphanet journal of rare diseases
ISSN: 1750-1172